Oct. 19, 2023
|
Thune, Hassan, Blackburn Introduce the SAVE IMD Options Act
|
Sen. Maggie Hassan
|
Nov. 4, 2022
|
Following Push from Senator Hassan, Administration Expands Opioid Treatment Options By Telehealth
|
Sen. Maggie Hassan
|
Sept. 19, 2022
|
Kuster, Miller-Meeks, Murphy, and Barragán Introduce Bipartisan Bill to Lower Drug Prices, Expedite Substitution Process for Pharmaceuticals
|
Rep. Annie Kuster
|
Sept. 13, 2022
|
Senators Baldwin, Shaheen Introduce Legislation to Give Local and Tribal Communities Tools to Combat the Opioid and Substance Use Disorder Epidemic
|
Sen. Jeanne Shaheen, ...
|
July 26, 2022
|
Senator Hassan Pushes to Address Fentanyl Overdoses & Substance Misuse During Senate Hearing
|
Sen. Maggie Hassan
|
July 25, 2022
|
Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars
|
Sen. Maggie Hassan, ...
|
July 21, 2022
|
Letter to Robert Califf, Commissioner of the Food and Drug Administration - Senators Hassan and Paul Press FDA to Increase Access to Life-Saving Naloxone
|
Sen. Maggie Hassan, ...
|
June 29, 2022
|
Shaheen Statement on New DOJ Initiative to Combat Substance Use Disorder Epidemic in New England
|
Sen. Jeanne Shaheen
|
June 9, 2022
|
NEW: Shaheen Ushers Numerous National Security Measures through Senate Foreign Relations Committee
|
Sen. Jeanne Shaheen
|
June 8, 2022
|
Bipartisan Addiction and Mental Health Task Force Hosts Roundtable with ONDCP Director
|
Rep. Annie Kuster
|
May 20, 2022
|
Shaheen, Hassan & Pappas Participate in Roundtable Discussion on Substance Use Prevention and Treatment Efforts with ONDCP Director Gupta
|
Sen. Jeanne Shaheen
|
May 19, 2022
|
NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding
|
Rep. Chris Pappas
|
May 19, 2022
|
NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding
|
Sen. Jeanne Shaheen
|
May 19, 2022
|
NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding ?
|
Rep. Annie Kuster
|
May 10, 2022
|
Pappas Statement on National Fentanyl Awareness Day
|
Rep. Chris Pappas
|
May 9, 2022
|
Pappas, Bacon, Lead Bipartisan Call for HHS to Update Opioid PHE Declaration to Include Methamphetamines
|
Rep. Chris Pappas
|
May 6, 2022
|
Feinstein, Grassley, Colleagues Seek to Deter Counterfeit Pill Production
|
Sen. Maggie Hassan, ...
|
April 29, 2022
|
Shaheen Encourages Granite Staters to Participate in Drug Take Back Day
|
Sen. Jeanne Shaheen
|
April 28, 2022
|
Pappas, Salazar, Lead Bipartisan Call for DHS to Adopt Common Operating Platform to Bolster Anti-Trafficking Efforts
|
Rep. Chris Pappas
|
April 21, 2022
|
Kuster Statement on Priorities of ONDCP, Emphasizes Importance of Reducing Demand and Interrupting Supply of Illicit Drugs
|
Rep. Annie Kuster
|
April 12, 2022
|
Senator Shaheen, Hassan Join Push to Make Naloxone Available Over the Counter
|
Sen. Jeanne Shaheen
|
April 11, 2022
|
Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
|
Sen. Maggie Hassan, ...
|
April 1, 2022
|
Pappas Statement on MORE Act Vote
|
Rep. Chris Pappas
|
March 31, 2022
|
Congressmen Gonzales and Pappas Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web
|
Rep. Chris Pappas, ...
|
March 30, 2022
|
Pappas Urges Adoption for Amendment to Close MORE Act Loopholes for Drug Traffickers and Violent Felons
|
Rep. Chris Pappas
|
March 30, 2022
|
Pappas and Gonzales Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web
|
Rep. Chris Pappas
|
March 30, 2022
|
Reps. Pappas, Axne, Buschon, and Miller-Meeks Introduce Bill to Expand Access to Opioid Use Disorder Treatment
|
Rep. Chris Pappas
|
March 28, 2022
|
Shaheen & Rep. Gottheimer Lead Bicameral Legislation to Prevent Opioid Misuse Among Students and Student Athletes
|
Sen. Jeanne Shaheen
|
March 16, 2022
|
Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices
|
Sen. Maggie Hassan, ...
|
March 14, 2022
|
Kuster, Pappas Question Law Enforcement on Evolving Addiction Crisis in New Hampshire
|
Rep. Annie Kuster
|
March 10, 2022
|
Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
|
Sen. Jeanne Shaheen, ...
|
March 10, 2022
|
Senators Shaheen, Capito, Reps. McKinley, Thompson Introduce Bipartisan Access to Prescription Digital Therapeutics Act
|
Sen. Jeanne Shaheen
|
March 7, 2022
|
Ahead of March 11 Temporary Scheduling Expiration Date, Pappas, Newhouse, and Budd to Introduce Bipartisan Save Americans from the Fentanyl Emergency Act of 2022
|
Rep. Chris Pappas, ...
|
March 1, 2022
|
Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
|
Sen. Maggie Hassan, ...
|
Feb. 25, 2022
|
Letter to Chuck Schumer, Senate Majority Leader, Patrick Leahy, Chair of the Senate Appropriations Committee, Chris Murphy, Chair of the Senate Subcommittee on Homeland Security - Peters Calls for Robust Funding to Support DHS Border Security and Drug Detection
|
Sen. Maggie Hassan, ...
|
Feb. 16, 2022
|
Senator Hassan, Colleagues Urge DOJ to Investigate Sackler Family Members for Role in Fueling Substance Misuse Crisis
|
Sen. Maggie Hassan
|
Feb. 16, 2022
|
Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
|
Sen. Maggie Hassan, ...
|
Feb. 15, 2022
|
Senator Hassan Votes Against Confirming FDA Commissioner Nominee, Robert Califf
|
Sen. Maggie Hassan
|
Feb. 8, 2022
|
Pappas Votes to Prevent Government Shutdown, Reiterates Call to Pass Full Appropriations Bill for FY 2022
|
Rep. Chris Pappas
|
Feb. 1, 2022
|
Pappas Reiterates Call for Congressional Action to Lower Prescription Drug Prices
|
Rep. Chris Pappas
|
Jan. 26, 2022
|
McBath Joins Colleagues to Introduce Bipartisan Bill to Prevent Substance Abuse Among Students
|
Rep. Chris Pappas, ...
|
Jan. 12, 2022
|
Pappas, Buchanan Lead Bipartisan Call to Stop Fentanyl Trafficking
|
Rep. Chris Pappas
|
Dec. 21, 2021
|
NH Delegation Welcomes $4.7 Million to Support Individuals & Families Impacted by Substance Use Disorders
|
Rep. Chris Pappas, ...
|
Dec. 21, 2021
|
Van Hollen, Warren, Baldwin, Maloney Reintroduce Landmark CARE Act to Combat the Substance Use Epidemic
|
Rep. Annie Kuster, ...
|
Dec. 20, 2021
|
NH Delegation Welcomes $1.6 Million to Combat Substance Use Disorder Crisis through NH Drug Court Program
|
Sen. Maggie Hassan, ...
|
Dec. 16, 2021
|
Baldwin, Warren, Maloney Lead More than 100 Democrats in Senate and House in Reintroducing Landmark CARE Act to Combat the Substance Use Epidemic
|
Rep. Annie Kuster, ...
|
Dec. 14, 2021
|
Kuster Applauds Announcement of $30 Million Funding Opportunity to Help Address the Substance Use and Overdose Epidemic Through Harm Reduction
|
Rep. Annie Kuster
|
Dec. 2, 2021
|
Kuster Urges Passage of Her Bipartisan STOP Fentanyl Act During Energy & Commerce Hearing
|
Rep. Annie Kuster
|
Nov. 17, 2021
|
Bipartisan Addiction and Mental Health Task Force Statement on U.S. Drug Overdose Deaths Surpassing 100,000 in 12-Month Period
|
Rep. Annie Kuster
|
Nov. 2, 2021
|
Following Pappas's Advocacy, Deal Announced to Include Prescription Drug Pricing Reforms in Build Back Better Legislation
|
Rep. Chris Pappas
|